Research Collaboration and License AgreementStock Purchase Agreement • November 5th, 2015 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
This Stock Purchase Agreement (this “Agreement”), effective as of [_______], 201_ (the “Effective Date”), is entered into by and between INBRX 110, LP, a Delaware limited partnership (“Inhibrx”), and Five Prime Therapeutics, Inc., a Delaware corporation (“FivePrime”). Inhibrx and FivePrime are referred to individually as a “Party” and collectively as the “Parties”.
